N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain

Journal of Neurochemistry

Volumn 98, Issue 5, 2006, Pages 1487-1496

  Faucard, Raphaël ^a   Armand, Vincent ^a   Héron, Anne ^b   Cochois, Véronique ^b   Schwartz, Jean Charles ^a   Arrang, Jean Michel ^a  

^a CENTRE PAUL BROCA   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Glutamate; H3 receptor; Histaminergic neurons; N methyl D aspartate receptor; Schizophrenia; Tuberomammillary nucleus

Indexed keywords

CIPROXIFAN; DIZOCILPINE; HISTAMINE; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST INVERSE AGONIST; HISTIDINE DECARBOXYLASE; IFENPRODIL; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; POLYAMINE; TELE METHYLHISTAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EVALUATION; FEMALE; GENE; HDC GENE; HIPPOCAMPUS; HYPERACTIVITY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; SCHIZOPHRENIA; TUBEROMAMMILLARY NUCLEUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENE EXPRESSION; HISTAMINE; HISTAMINE ANTAGONISTS; HISTIDINE DECARBOXYLASE; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METHYLHISTAMINES; MICE; MOTOR ACTIVITY; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

RODENTIA;

EID: 33746888677     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04002.x     Document Type: Article

References (58)

1. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E. and Sandberg M. (1999) Characterization of MK-801-induced behavior as a putative rat model of psychosis. J. Pharmacol. Exp. Ther. 290, 1393-1408.
2. 3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol. Dis. 8, 707-716.
3. Anis N. A., Berry S. C., Burton N. R. and Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methylaspartate. Br. J. Pharmacol. 79, 565-575.
4. 3-receptors. Nature 327, 117-123.
5. 3-receptors in rat brain. Eur. J. Pharmacol. 157, 31-35.
6. 3 receptor antagonists thioperamide and ciproxifan. Behav. Brain Res. 153, 69-76.
7. Brown R. E., Stevens D. R. and Haas H. L. (2001) The physiology of brain histamine. Prog. Neurobiol. 63, 637-672.
8. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
9. Carter C., Benavides J., Legendre P., Vincent J. D., Noel F., Thuret F., Lloyd K. G., Arbilla S., Zivkovic B. and MacKenzie E. T. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J. Pharmacol. Exp. Ther. 247, 1222-1232.
10. Chemelli R. M., Willie J. T., Sinton C. M. et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451.
11. Chenard B. L. and Menniti F. S. (1999) Antagonists selective for NMDA receptors containing the NR2B subunit. Curr. Pharm. Des. 5, 381-404.
12. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur. J. Pharmacol. 259, 107-114.
13. Coyle J. T., Tsai G. and Goff D. (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. NY Acad. Sci. 1003, 318-327.
14. Eyigor O., Centers A. and Jennes L. (2001) Distribution of ionotropic glutamate receptor subunit mRNAs in the rat hypothalamus. J. Comp. Neurol. 434, 101-124.
15. Fekete C. S., Strutton P. H., Cagampang F. R. et al. (1999) Estrogen receptor immunoreactivity is present in the majority of central histaminergic neurons: evidence for a new neuroendocrine pathway associated with luteinizing hormone-releasing hormone-synthesizing neurons in rats and humans. Endocrinology 140, 4335-4341.
16. 3 receptor antagonist. J. Pharmacol. Exp. Ther. 313, 176-190.
17. Fraser C. M., Cooke M. J., Fisher A., Thompson I. D. and Stone T. W. (1996) Interactions between ifenprodil and dizocilpine on mouse behaviour in models of anxiety and working memory. Eur. Neuropsychopharmacol. 6, 311-316.
18. Garbarg M., Pollard H., Trung Tuong M. D., Schwartz J. C. and Gros C. (1989) Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain. J. Neurochem. 53, 1724-1730.
19. 3 receptor agonist. J. Pharmacol. Exp. Ther. 263, 304-310.
20. + channels. Neuron 31, 1027-1034.
21. Ishunina T. A., van Heerikhuize J. J., Ravid R. and Swaab D. F. (2003) Estrogen receptors and metabolic activity in the human tubero-mamillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Brain Res. 988, 84-96.
22. Ito C., Onodera K., Sakurai E., Sato M. and Watanabe T. (1996) Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J. Pharmacol. Exp. Ther. 279, 271-276.
23. Itoh Y., Oishi R., Nishibori M. and Saeki K. (1985) Phencyclidine and the dynamics of mouse brain histamine. J. Pharmacol. Exp. Ther. 235, 788-792.
24. Itoh Y., Oishi R., Nishibori M. and Saeki K. (1986) Comparison of effects of phencyclidine and methamphetamine on body temperature in mice: a possible role for histamine neurons in thermoregulation. Naunyn Schmiedebergs Arch. Pharmacol. 332, 293-296.
25. Itoh Y., Oishi R., Nishibori M. and Saeki K. (1987) Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice. Naunyn Schmiedebergs Arch. Pharmacol. 335, 285-289.
26. Itoh Y., Oishi R., Nishibori M. and Saeki K. (1988) Involvement of Mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J. Pharmacol. Exp. Ther. 244, 1021-1026.
27. Javitt D. C. and Zukin S. R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
28. Jentsch J. D. and Roth R. H. (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
29. Joseph D. R., Sullivan P. M., Wang Y. M., Kozak C., Fenstermacher D. A., Behrendsen M. E. and Zahnow C. A. (1990) Characterization and expression of the complementary DNA encoding rat histidine decarboxylase. Proc. Natl Acad. Sci. USA 87, 733-737.
30. Kew J. N., Trube G. and Kemp J. A. (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J. Physiol. 497, 761-772.
31. 3-receptor antagonist. J. Pharmacol. Exp. Ther. 287, 658-666.
32. 3) visualized in the brain of human and non-human primates. Brain Res. 526, 322-327.
33. 2A receptor blockade. J. Pharmacol. Exp. Ther. 288, 590-596.
34. 3 receptors regulates histamine neurons in brain. Nature 408, 860-864.
35. 3 receptor. J. Pharmacol. Exp. Ther. 300, 621-628.
36. 3 receptor antagonist thioperamide in rats. Eur. J. Pharmacol. 363, 93-101.
37. 3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29, 705-717.
38. Nabeshima T., Yamaguchi K., Furukawa H. and Kameyama T. (1984) Role of sex hormones in sex-dependent differences in phencyclidine-induced stereotyped behaviors in rats. Eur. J. Pharmacol. 105, 197-206.
39. Nishibori M., Oishi R., Itoh Y. and Saeki K. (1985) Morphine-induced changes in histamine dynamics in mouse brain. J. Neurochem. 45, 719-724.
40. Okakura K., Yamatodani A., Mochizuki T., Horii A. and Wada H. (1992) Glutamatergic regulation of histamine release from rat hypothalamus. Eur. J. Pharmacol. 213, 189-192.
41. Onodera K., Yamatodani A., Watanabe T. and Wada H. (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42, 685-702.
42. 3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat. J. Neurosci. 22, 7272-7280.
43. 3 receptor and its gene transcripts in rat brain. Neuroscience 114, 173-193.
44. 3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. Eur. J. Neurosci. 17, 307-314.
45. Prell G. D., Green J. P., Kaufmann C. A., Khandelwal J. K., Morrishow A. M., Kirch D. G., Linnoila M. and Wyatt R. J. (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr. Res. 14, 93-104.
46. 3 heteroreceptors. Fundam. Clin. Pharmacol. 8, 128-137.
47. Schwartz J. C. and Arrang J. M. (2002) Histamine, in Neuropsychopharmacology: the Fifth Generation of Progress. (Davis, K. L., Charney, D., Coyle, J. T. and Nemeroff, C., eds), pp. 179-190. Lippincott, Williams & Wilkins, Philadelphia.
48. Schwartz J. C., Arrang J. M., Garbarg M., Gulat-Marnay C. and Pollard H. (1990) Modulation of histamine synthesis and release in brain via presynaptic autoreceptors and heteroreceptors. Ann. NY Acad. Sci. 604, 40-54.
49. Schwartz J. C., Arrang J. M., Garbarg M., Pollard H. and Ruat M. (1991) Histaminergic transmission in the mammalian brain. Physiol. Rev. 71, 1-51.
50. Shelnutt S. R., Gunnell M. and Owens S. M. (1999) Sexual dimorphism in phencyclidine in vitro metabolism and pharmacokinetics in rats. J. Pharmacol. Exp. Ther. 290, 1292-1298.
51. Sherin J. E., Shiromani P. J., McCarley R. W. and Saper C. B. (1996) Activation of ventrolateral preoptic neurons during sleep. Science 271, 216-219.
52. Sherin J. E., Elmquist J. K., Torrealba F. and Saper C. B. (1998) Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 18, 4705-4721.
53. Stevens D. R., Eriksson K. S., Brown R. E. and Haas H. L. (2001) The mechanism of spontaneous firing in histamine neurons. Behav. Brain Res. 124, 105-112.
54. Torrealba F., Yanagisawa M. and Saper C. B. (2003) Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 1033-1044.
55. Williams K. (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859.
56. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N. and Iversen L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl Acad. Sci. USA 83, 7104-7108.
57. Yanai K., Zhao X. L. and Watanabe T. (1997) Excitotoxic lesions of histaminergic neurons by excitatory amino acid agonists in the rat brain. Neurosci. Lett. 232, 159-162.
58. Yang Q. Z. and Hatton G. I. (1997) Electrophysiology of excitatory and inhibitory afferents to rat histaminergic tuberomammillary nucleus neurons from hypothalamic and forebrain sites. Brain Res. 773, 162-172.